Global Epithelial Cell Adhesion Molecule Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Epithelial Cell Adhesion Molecule Market Research Report 2024
Epithelial cell adhesion molecule is a transmembrane glycoprotein mediating Ca2+-independent homotypic cell–cell adhesion in epithelia.EpCAM is also involved in cell signaling,migration,proliferation, and differentiation.Additionally, EpCAM has oncogenic potential via its capacity to upregulate c-myc, e-fabp, and cyclins A & E.Since EpCAM is expressed exclusively in epithelia and epithelial-derived neoplasms, EpCAM can be used as diagnostic marker for various cancers. It appears to play a role in tumorigenesis and metastasis of carcinomas, so it can also act as a potential prognostic marker and as a potential target for immunotherapeutic strategies.
According to Mr Accuracy reports’s new survey, global Epithelial Cell Adhesion Molecule market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epithelial Cell Adhesion Molecule market research.
Key companies engaged in the Epithelial Cell Adhesion Molecule industry include Cell Signaling Technology, BioLegend, Thermo Fisher Scientific, Sino Biological, ACROBiosystems, R&D Systems and OriGene Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Epithelial Cell Adhesion Molecule were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Epithelial Cell Adhesion Molecule market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epithelial Cell Adhesion Molecule market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cell Signaling Technology
BioLegend
Thermo Fisher Scientific
Sino Biological
ACROBiosystems
R&D Systems
OriGene Technologies
Segment by Type
Primary Structure
Secondary Structure
Other
Laboratory
Medical Care
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Epithelial Cell Adhesion Molecule report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Epithelial Cell Adhesion Molecule market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Epithelial Cell Adhesion Molecule market research.
Key companies engaged in the Epithelial Cell Adhesion Molecule industry include Cell Signaling Technology, BioLegend, Thermo Fisher Scientific, Sino Biological, ACROBiosystems, R&D Systems and OriGene Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Epithelial Cell Adhesion Molecule were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Epithelial Cell Adhesion Molecule market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Epithelial Cell Adhesion Molecule market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cell Signaling Technology
BioLegend
Thermo Fisher Scientific
Sino Biological
ACROBiosystems
R&D Systems
OriGene Technologies
Segment by Type
Primary Structure
Secondary Structure
Other
Segment by Application
Laboratory
Medical Care
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Epithelial Cell Adhesion Molecule report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices